Further, qRT-PCR analysis confirmed that JIB-04 treatment and MECOM siRNA-mediated silencing reduced SUB1 transcript levels in ovarian tumor cells (Fig. 8I, J). Here, SUB1 is linked to ovarian neoplasm.